or Try an Advanced Search...

    Macular Edema Stocks List

    Symbol Grade Name % Change
    OCS A Oculis Holding AG -0.25
    RZLT B Rezolute, Inc. -10.03
    EPRX B Eupraxia Pharmaceuticals Inc. -2.40
    OPT B Opthea Limited 5.83
    REGN D Regeneron Pharmaceuticals, Inc. -1.75
    CLSD D Clearside Biomedical, Inc. -5.97
    EYPT D EyePoint Pharmaceuticals, Inc. -1.88
    ALIM F Alimera Sciences, Inc. -8.82
    KALV F KalVista Pharmaceuticals, Inc. 1.35
    AMPE F Ampio Pharmaceuticals, Inc. 0.00
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Major Shell Companies
    Related Stock Lists: Diabetic Macular Edema Biopharmaceutical Medicine Diabetic Retinopathy Eye Diabetes Macular Degeneration Ophthalmology Organ Systems Biotechnology Blindness Disease Eye Diseases Inflammation Clinical Development Diketones Dry Eye Disease Fluocinolone Glucocorticoids Kallikrein

    Related ETFs - A few ETFs which own one or more of the above listed Macular Edema stocks.

    Symbol Grade Name Weight
    IBBQ D Invesco Nasdaq Biotechnology ETF 8.24
    IBB D iShares Nasdaq Biotechnology Index Fund 8.12
    BBH D Market Vectors Biotech ETF 7.74
    PBE D PowerShares Dynamic Biotech & Genome 7.21
    BIB D ProShares Ultra Nasdaq Biotechnology 6.07
    View all Macular Edema ETFs...
    Compare ETFs
    Compare BBH to BIB Compare IBBQ to IBB Compare IBBQ to PBE

        Macular Edema Stocks Recent News

        Date Stock Title
        Apr 25 REGN AbbVie's Dermatitis Drug Shown 'Superior' To Sanofi/Regeneron's Dupixent In Head-To-Head Study
        Apr 25 REGN Heard on the Street: Bristol-Myers Goes From Big Pharma to Little Pharma
        Apr 25 REGN Regeneron (REGN) Reports Next Week: What You Should Expect
        Apr 25 OPT Opthea to Present at the OIS Retina Innovation Summit at ARVO
        Apr 25 REGN UPDATE 1-AbbVie's skin disease drug found to be more effective than Regeneron's Dupixent in study
        Apr 25 REGN The Zacks Analyst Blog Highlights Danaher, Regeneron Pharmaceuticals, Palo Alto Networks, Workday and American Electric Power
        Apr 25 REGN Regeneron, Mammoth in pact to develop CRISPR-based gene editing therapies
        Apr 25 REGN Regeneron to collaborate on gene editing therapies with Doudna-founded Mammoth
        Apr 25 REGN Regeneron and Mammoth Biosciences Collaborate to Pursue Next-Generation CRISPR-Based Gene Editing for Multiple Diseases
        Apr 25 REGN Regeneron expands in gene editing with Mammoth deal
        Apr 24 REGN Top Stock Reports for Danaher, Regeneron Pharmaceuticals & Palo Alto Networks
        Apr 24 REGN Regeneron to Showcase Progress in Advancing Novel Investigational Treatment Approaches for a Broad Range of Solid Tumors and Blood Cancers at ASCO
        Apr 23 EYPT Over $10M Bet On This Healthcare Stock? Check Out These 4 Stocks Insiders Are Buying
        Apr 23 RZLT Phase 2 RIZE Study Sub-Analyses to be Presented at the 2024 Pediatric Endocrine Society Annual Meeting
        Apr 22 REGN Regeneron to Highlight Advances in Genetic Medicine Research at American Society of Gene and Cell Therapy (ASGCT)
        Apr 22 OCS Oculis Announces Closing of Registered Direct Offering and Commencement of Trading on Nasdaq Iceland Main Market
        Apr 22 KALV KalVista Pharmaceuticals Appoints William C. Fairey to Board of Directors
        Apr 22 REGN Agenus (AGEN) Soars 6.8%: Is Further Upside Left in the Stock?
        Apr 19 REGN Regeneron Pharmaceuticals Insiders Sell US$26m Of Stock, Possibly Signalling Caution
        Related Industries: Biotechnology Drug Manufacturers - Major Shell Companies
        Related Stock Lists: Diabetic Macular Edema Biopharmaceutical Medicine Diabetic Retinopathy Eye Diabetes Macular Degeneration Ophthalmology Organ Systems Biotechnology Blindness Disease Eye Diseases Inflammation Clinical Development Diketones Dry Eye Disease Fluocinolone Glucocorticoids Kallikrein
        Macular Edema

        Macular edema is a condition in which fluid accumulates in the macula, the part of the eye responsible for central vision. It can cause blurred vision, difficulty reading, and other vision problems. Macular edema can be caused by a variety of conditions, including diabetes, retinal vein occlusion, and uveitis. Treatment may include medications, laser therapy, or surgery.

        Browse All Tags